PubMed Health⌕ Search

Biomedical subjects

V Ferreira Montero

Publications and source records attributed to V Ferreira Montero.

15 recordsLinked to original sources
PubMed1997

Primary malignant fibrous histiocytoma of the jejunum: report of a case and review of subject.

We report a new case of primary malignant fibrous histiocytoma of the jejunum. Malignant fibrous histiocytoma (MFH) occurs most commonly in the extremities and trunk, but rarely in visceral organs. However, only eight cases of primary tumours involving the small intestine, including the present, have been described. This case report documents the appearance of malignant fibrous histiocytoma as a primary lesion of the intestinal wall in a patient with a 2-month history of dyspepsia, weight loss and unspecific abdominal pain. The final diagnosis was based on the pathological report of the surgical specimen. Emphasis is placed on the clinical signs, radiological studies and pathological findings. The literature on MFH of the jejunum is also reviewed. Malignant fibrous histiocytoma is considered an aggressive tumour, and the treatment of choice is complete surgical excision. Adjuvant chemotherapy or radiation is recommended mainly in those patients in whom there is vascular or lymphatic infiltration.

Combined Modality Therapy↗
PubMed1983

[Cerebral metastasis, idiopathic pneumoperitoneum and obstructive jaundice as clinical manifestations of carcinoma of the pancreas].

A case of undifferentiated pancreatic carcinoma is described. The first symptoms were due to brain metastases and was then diagnosed as malignant glioma. The appearance of a sudden obstructive jaundice and pneumoperitoneum without any apparent cause led to the diagnosis of undifferentiated pancreatic carcinoma and peritoneal carcinomatosis, that was confirmed by the anatomicopathological study.

Adenocarcinoma↗
PubMed1980

Usefulness of caerulein in the treatment of post-operative intestinal atony.

We conducted a controlled clinical trial designed to test caerulein for tolerability and effectiveness in post-operative patients recovering from abdominal surgery. The test product was administered 24 hours after surgery, by intravenous drip infusion, at the rate of 2 nanograms/kg/minute. The results were compared with parallel observations made in a matched group of patients receiving no drugs or manipulation likely to promote intestinal peristalsis with the exception of the application of a nasogastric tube for aspiration and the water and electrolyte replenishment customary in the post-operative period. The results of this study evince a clear-cut difference between the two groups of patients in regard to the restoration of intestinal peristalsis and the passing of flatus and faeces, as confirmed by statistical analysis (Cochran's test) demonstrating the significant (p less than 0.01) superiority of caerulein treatment relative to the untreated control group. Likewise, the study revealed the excellent tolerability of the test drug at the dosage employed.

Ceruletide↗